HOXB13 and prostate carcinoma: Strongest risk effects within the hereditary prostate cancer case subset of the NFPCS were observed for rs559612720 (P = 0.0096, OR = 16.2) and rs138213197 (HOXB13 G84E, P = 0.0025, OR = 10.8).